BusinessBioSig Announces Submission of FDA 510(k) Application for PURE EP SystemBy Nasdaq OMXMar 28, 2018, 12:01 PM UTC
BusinessDrug Master File for Prostate Imaging Product Filed with the FDABy Nasdaq OMXMar 26, 2018, 12:00 PM UTC
BusinessRitter Pharmaceuticals Announces 1-for-10 Reverse Stock SplitBy Nasdaq OMXMar 22, 2018, 3:35 PM UTC
BusinessRitter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMar 19, 2018, 10:35 AM UTC
BusinessAbstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & ExpositionBy Nasdaq OMXMar 14, 2018, 11:45 AM UTC
BusinessActinium Pharmaceuticals Announces Appointment of Jehan Rowlands, Pharm.D. as Vice-President, Head of Regulatory AffairsBy Nasdaq OMXMar 14, 2018, 11:30 AM UTC
BusinessActinium Announces FDA Clearance of IND For Phase 1 trial of Actimab-A in Combination with CLAG-M for Patients with Relapsed or Refractory AMLBy Nasdaq OMXMar 13, 2018, 11:30 AM UTC
BusinessFirst Comprehensive Clinical Site Initiation Benchmark, Developed by Tufts Center for the Study of Drug Development, Finds Study Startup Is Lengthy and InefficientBy Nasdaq OMXMar 7, 2018, 2:01 PM UTC
